Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by canadafanon Jan 09, 2025 6:06am
154 Views
Post# 36395622

RE:Fun day today…

RE:Fun day today…

My statement fun dat today.......had zero to do with Onc share price.
inhad a fun day, & as I said don't normally post during the week.

what has been fun. I spite of myself & others praising notable, he finds a need to critizez me
then a very dillusional theory, thst somehow my posting drives the price down?
What about when I post & the price is up? since both happen randomly.
moving on ....
We are now in the stretch before the presentation at JP Morgan conference.Being the 13th.
followed a week later by the most recent Gobblet cohort, on anal cancer. They specifically mentioned in NR, thst efficacy will be revealed....perhaps a third enabling trial. & yet another reason for Roche to buy Onc out. 

That is my first pick. As being obvious, it enhances their existing product, plus the sales from Pela. 
No down side. Just need to agree on a price.
obviously much much more than present trading range. & as I discussed, a premium to the highest analysts prediction.
JPmorgan.
I had no idea the size of that event. hundreds of pharma, biotech & clinical support companies.
certianly will be exciting times ahead.
reinerate, I spoke in person with financial people & other investors. All said, I'm very glad I bought 30% more shares a few weeks back. & no I have not sold any.
Im in until Onc does a deal.
A buyout, would decide for me.

 

 

<< Previous
Bullboard Posts
Next >>